U.S. lifts ban on Malaysian medical glove maker amid shortage

by Reuters
Wednesday, 25 March 2020 01:15 GMT

A researcher puts on protective gloves at the Microbiology Research Facility where researchers are beginning a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of coronavirus disease (COVID-19) at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig

Image Caption and Rights Information

The glove maker was accused of using forced labour but the US said conditions had improved

KUALA LUMPUR, March 25 (Reuters) - The United States has lifted a ban on a Malaysian medical glove maker it had accused of using forced labour, a government statement showed, amid a surge in demand for personal protective equipment to fight the coronavirus crisis.

The U.S. Customs and Border Protection (CBP) on Tuesday said disposable rubber gloves made by WRP Asia Pacific Sdn Bhd after March 16, 2020, will be admissible at all U.S. ports of entry.

The ban placed on WRP in September "was revoked based on recent information obtained by CBP showing the company is no longer producing the rubber gloves under forced labor conditions", CBP said in the statement.

"We are very pleased that this effort successfully mitigated a significant supply chain risk and resulted in better working conditions and more compliant trade," said Brenda Smith, CBP's executive assistant commissioner for the office of trade.

WRP, which has the capacity to produce more than 11 billion gloves a year, could not immediately be contacted for comment.

Malaysia is the world's biggest producer of medical gloves. The gloves are in huge demand because of the spread of the virus that has infected more than 377,000 people across 194 countries and territories as of early Tuesday, according to a Reuters tally, with more than 16,500 deaths.

The United States is the world's biggest consumer of medical gloves per person.

(Reporting by Krishna N. Das; Editing by Christopher Cushing)

Our Standards: The Thomson Reuters Trust Principles.